A poison pill, formally a shareholder rights plan, deters an unapproved ownership accumulation through specified rights and dilution triggers.
A poison pill, formally called a shareholder rights plan, is a takeover defense designed to deter a person or group from crossing a specified ownership threshold without board approval. If the plan is triggered, shareholders other than the triggering acquirer can receive or exercise rights on favorable terms, creating potentially severe dilution for the acquirer.
The plan does not automatically prevent a sale of the company. It usually gives the board time and bargaining leverage because a bidder must negotiate for redemption or waiver, stay below the trigger, replace directors, challenge the plan, or pursue another permitted route.
The company enters into a rights agreement and distributes one or more rights associated with each outstanding common share. Before a trigger, the rights may trade with the common shares and have little separate economic effect.
The agreement specifies the ownership threshold and how direct, indirect, derivative, affiliate, associate, and group holdings are counted. It may exempt existing large holders, passive institutions, employee plans, approved acquisitions, or inadvertent crossings.
No universal trigger applies. A conventional takeover plan and a plan intended to protect net operating loss tax attributes can use materially different thresholds and definitions.
If a person becomes an “acquiring person” under the agreement, the rights can separate from the common shares or become exercisable. The triggering acquirer does not receive the same favorable economics.
Non-triggering holders may receive the right to purchase target-company shares or equivalent value at a substantial discount. If exercised or exchanged, those rights increase the share base and reduce the acquirer’s percentage ownership and voting power.
Depending on the agreement and law, the board may redeem the rights before a deadline, exchange rights for shares, amend the plan, exempt a transaction, or allow it to expire. These powers are not unlimited and should be read from the actual agreement.
Assume a company has 100 million shares outstanding. A bidder acquires 15 million shares and triggers a plan at 15%. The plan permits the other 85 million shares to receive one new share each at a deeply discounted effective price, and all eligible rights are exercised.
| Item | Before exercise | After illustrative exercise |
|---|---|---|
| Bidder shares | 15 million | 15 million |
| Other-holder shares | 85 million | 170 million |
| Total shares | 100 million | 185 million |
| Bidder ownership | 15.0% | 8.1% |
The bidder’s stake falls from 15% to about 15 / 185 = 8.1%. To restore its former percentage, the bidder would need to acquire many more shares, assuming it could do so legally and without triggering additional consequences.
This simplified example ignores exercise proceeds, exchange ratios, options, derivatives, tax effects, and the exact rights formula. Actual dilution can be structured differently and should be modeled from the filed rights agreement.
| Feature | Question to ask |
|---|---|
| Trigger threshold | At what beneficial-ownership percentage does a holder become an acquiring person? |
| Beneficial ownership | How are affiliates, groups, derivatives, voting agreements, and rights to acquire shares treated? |
| Flip-in rights | What can non-acquiring holders purchase or receive after the trigger? |
| Flip-over rights | Do rights apply to securities of a surviving or acquiring company after a later combination? |
| Redemption | Can the board cancel the rights for a nominal amount before or after specified events? |
| Exchange | Can the company exchange rights for shares instead of requiring exercise? |
| Exemptions | Which existing, passive, approved, or inadvertent holders are excluded? |
| Duration | When does the plan expire, and can it be renewed? |
| Qualifying offer | Can specified offers lead to shareholder action or another path around the plan? |
| Dead-hand feature | Does the plan restrict which directors can redeem it, and is that feature valid in the jurisdiction? |
Plan summaries often omit decisive definitions. Read the complete agreement and all amendments.
The board may conclude that rapid stake accumulation, a coercive offer structure, inadequate price, or insufficient decision time threatens the corporation or shareholders.
A bidder that cannot cross the trigger economically may negotiate with the board, potentially improving price, financing certainty, conditions, or treatment of holders.
The plan can provide time to evaluate the bid, solicit a White Knight, pursue a recapitalization, or present a standalone strategy.
Some rights plans are designed to limit ownership changes that could impair use of net operating losses or other tax attributes. The threshold and purpose can differ from a conventional takeover pill, and the plan cannot guarantee preservation or realization of the tax asset.
| Potential benefit | Corresponding concern |
|---|---|
| Gives the board time to evaluate an offer | Delays shareholders from accepting an offer they prefer |
| Strengthens negotiating leverage | Can protect incumbent positions |
| Deters coercive or partial accumulations | Can discourage legitimate bids and market discipline |
| Supports a search for alternatives | Alternative plans may be speculative or value-destructive |
| Protects specified tax attributes | Estimated tax value may be uncertain or unusable |
The relevant question is not whether poison pills are always good or bad. It is whether this plan, adopted through this process, is a proportionate response to an identified threat and preserves a credible route to shareholder value under applicable law.
| Defense | Main mechanism | Key distinction |
|---|---|---|
| Poison pill | Threatens asymmetric dilution after an ownership trigger | Directly constrains stake accumulation |
| Staggered board | Elects only part of the board in each cycle | Slows board replacement rather than diluting ownership |
| White knight | Seeks a more acceptable bidder | Creates a transaction alternative |
| Asset or crown-jewel defense | Sells, options, or restructures important assets | Changes target economics and can destroy value if misused |
| Self-tender | Company repurchases its own shares | Changes cash, leverage, share count, and ownership concentration |
| Litigation or regulatory response | Challenges conduct, disclosure, or approvals | Depends on legal merits and timing rather than dilution |
A Self-Tender Offer can be used during a defense but remains a capital-allocation transaction with separate funding and Rule 13e-4 considerations.
This page is educational and does not determine whether a board may adopt, maintain, trigger, redeem, or waive a rights plan. Those are fact-specific legal and governance questions requiring current documents and qualified counsel.
The Delaware Court of Chancery’s The Williams Companies Stockholder Litigation opinion reviews poison-pill history, the Moran decision, board authority, and fiduciary constraints under Delaware law. The SEC’s beneficial-ownership reporting interpretations are relevant when a bidder’s stake approaches reporting or plan thresholds. The SEC’s tender-offer filing reference identifies the separate federal tender-offer documents and rules.